Cargando…

Implementation of Pharmacogenetics to Individualize Treatment Regimens for Children with Acute Lymphoblastic Leukemia

Despite major advances in the management and high cure rates of childhood acute lymphoblastic leukemia (ALL), patients still suffer from many drug-induced toxicities, sometimes necessitating dose reduction, or halting of cytotoxic drugs with a secondary risk of disease relapse. In addition, investig...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maamari, Dimitri, El-Khoury, Habib, Saifi, Omran, Muwakkit, Samar A, Zgheib, Nathalie K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7429230/ https://www.ncbi.nlm.nih.gov/pubmed/32848445 http://dx.doi.org/10.2147/PGPM.S239602

Ejemplares similares

ITPA, TPMT, and NUDT15 Genetic Polymorphisms Predict 6-Mercaptopurine Toxicity in Middle Eastern Children With Acute Lymphoblastic Leukemia
por: Moradveisi, Borhan, et al.
Publicado: (2019)

P399: SUCCESSFUL IMPLEMENTATION OF A MODIFIED ST JUDE TOTAL XV PROTOCOL FOR TREATING CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA IN LEBANON. LESSONS FOR LOW- AND MIDDLE-INCOME COUNTRIES.
por: Ghaddar, Lara, et al.
Publicado: (2023)

Pharmacogenetics of asparaginase in acute lymphoblastic leukemia
por: Abaji, Rachid, et al.
Publicado: (2019)

Pharmacogenetic testing for thiopurine drugs in Brazilian acute lymphoblastic leukemia patients
por: Suarez-Kurtz, Guilherme, et al.
Publicado: (2023)

Population Analysis of Pharmacogenetic Polymorphisms Related to Acute Lymphoblastic Leukemia Drug Treatment
por: Chiabai, Marcela A., et al.
Publicado: (2012)

Editorial: Pharmacogenetics Research and Clinical Applications: An International Landscape of the Accomplishments, Challenges, and Opportunities
por: Zgheib, Nathalie K., et al.
Publicado: (2020)

Pharmacogenetics of MicroRNAs and MicroRNAs Biogenesis Machinery in Pediatric Acute Lymphoblastic Leukemia
por: López-López, Elixabet, et al.
Publicado: (2014)

Screening of Novel Pharmacogenetic Candidates for Mercaptopurine-Induced Toxicity in Patients With Acute Lymphoblastic Leukemia
por: Cao, Minyuan, et al.
Publicado: (2020)

A Pharmacogenetic Study of VDR fok1 and TYMS Polymorphisms and Their Association With Glucocorticoid-Induced Osteonecrosis in Egyptian Children With Acute Lymphoblastic Leukemia
por: ElHarouni, Dina, et al.
Publicado: (2018)

A proposal for an individualized pharmacogenetic-guided isoniazid dosage regimen for patients with tuberculosis
por: Jung, Jin Ah, et al.
Publicado: (2015)

Characterization of pharmacogenetic markers related to Acute Lymphoblastic Leukemia toxicity in Amazonian native Americans population
por: de Carvalho, Darlen Cardoso, et al.
Publicado: (2020)

Pharmacogenetics of the Central Nervous System—Toxicity and Relapse Affecting the CNS in Pediatric Acute Lymphoblastic Leukemia
por: Sági, Judit C., et al.
Publicado: (2021)

Pharmacogenetics of pediatric acute lymphoblastic leukemia in Uruguay: adverse events related to induction phase drugs
por: Burgueño-Rodríguez, Gabriela, et al.
Publicado: (2023)

Challenges in implementing individualized medicine illustrated by antimetabolite therapy of childhood acute lymphoblastic leukemia
por: Nersting, Jacob, et al.
Publicado: (2011)

Acute Lymphoblastic Leukemia Experience: Epidemiology and Outcome of Two Different Regimens
por: Abbasi, Salah, et al.
Publicado: (2013)

Pharmacogenetics of induction therapy-related toxicities in childhood acute lymphoblastic leukemia patients treated with UKALL 2003 protocol
por: Aslam, Sara, et al.
Publicado: (2021)

Pharmacogenetic Analysis of Pediatric Patients with Acute Lymphoblastic Leukemia: A Possible Association between Survival Rate and ITPA Polymorphism
por: Kim, Hyery, et al.
Publicado: (2012)

Outcomes of a Modified CALGB 19802 Regimen in Adult Acute Lymphoblastic Leukemia
por: Han, A-Reum, et al.
Publicado: (2008)

Venetoclax for Children and Adolescents with Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma
por: Gibson, Amber, et al.
Publicado: (2021)

Comparison of FDA Table of Pharmacogenetic Associations and Clinical Pharmacogenetics Implementation Consortium guidelines
por: Pritchard, Daryl, et al.
Publicado: (2022)

A Proposal for an Individualized Pharmacogenetic-Guided Warfarin Dosage Regimen for Puerto Rican Patients Commencing Anticoagulation Therapy
por: Bosch, Luis Ángel Bermúdez
Publicado: (2014)

Correction to: Comparison of FDA Table of Pharmacogenetic Associations and Clinical Pharmacogenetics Implementation Consortium guidelines
Publicado: (2022)

Characterization of Acute Lymphoblastic Leukemia Subtypes in Moroccan Children
por: Bachir, Fatima, et al.
Publicado: (2009)

Pharmacogenetics of asthma in children
por: Kondo, Naomi, et al.
Publicado: (2010)

Effect of post-consolidation regimen on symptomatic osteonecrosis in three DCOG acute lymphoblastic leukemia protocols
por: van Atteveld, Jenneke E., et al.
Publicado: (2021)

A chemotherapy-free regimen for Philadelphia chromosome-positive acute lymphoblastic leukemia: are we there yet?
por: Ofran, Yishai
Publicado: (2021)

Towards the clinical implementation of pharmacogenetics in bipolar disorder
por: Salloum, Naji C, et al.
Publicado: (2014)

Human bocavirus in children with acute lymphoblastic leukemia
por: Koskenvuo, Minna, et al.
Publicado: (2007)

Norovirus Infection in Children with Acute Lymphoblastic Leukemia
por: Reddy, Nalla Anuraag, et al.
Publicado: (2023)

Expression level of CEBPA gene in acute lymphoblastic leukemia individuals
por: Szmajda, Dagmara, et al.
Publicado: (2019)

Pharmacogenetics in Africa, an Opportunity for Appropriate Drug Dosage Regimens: on the Road to Personalized Healthcare
por: Masimirembwa, C, et al.
Publicado: (2013)

Pharmacogenetics of BCR/ABL Inhibitors in Chronic Myeloid Leukemia
por: Polillo, Marialuisa, et al.
Publicado: (2015)

Implementation of Medication Safety Practice in Childhood Acute Lymphoblastic Leukemia Treatment
por: Mulatsih, Sri, et al.
Publicado: (2018)

Helpful Criteria When Implementing NGS Panels in Childhood Lymphoblastic Leukemia
por: Vega-Garcia, Nerea, et al.
Publicado: (2020)

The IGNITE Pharmacogenetics Working Group: An Opportunity for Building Evidence with Pharmacogenetic Implementation in a Real‐World Setting
por: Cavallari, LH, et al.
Publicado: (2017)

Efficacy and tolerability of a modified pediatric‐inspired intensive regimen for acute lymphoblastic leukemia in older adults
por: Patel, Anand Ashwin, et al.
Publicado: (2021)

Pediatric-Inspired Regimens in the Treatment of Acute Lymphoblastic Leukemia in Adolescents and Young Adults: A Systematic Review
por: Zeckanovic, Aida, et al.
Publicado: (2023)

The Successful Implementation of a Modified Pediatric Acute Lymphoblastic Leukemia Protocol to Treat an Elderly Patient With T-cell Lymphoblastic Leukemia: A Case Report
por: Motabi, Ibraheem H, et al.
Publicado: (2023)

ATP-Binding Cassette Transporters in the Clinical Implementation of Pharmacogenetics
por: López-Fernández, Luis A.
Publicado: (2018)

Pharmacogenetics to Avoid Adverse Reactions in Cardiology: Ready for Implementation?
por: García-González, Xandra, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_h8q346vd27kkpd4g2acpvns8p7